2BBBullish & Bearish
Health Care

Perspective Therapeutics (CATX) Stock Score & Signals

Perspective Therapeutics (CATX) trades on NYSEAMERICAN. It operates in the Health Care sector, Medical/Dental Instruments industry. Its current 2BB score is 40 out of 100.

About Perspective Therapeutics

Isoray Inc. is a national isotope-based medical company and the sole producer of Cesium brachytherapy sources, which are expanding brachytherapy treatments for difficult to treat cancers. Isoray is a registered manufacturer with the FDA and holds multiple 510 clearances for brachytherapy devices. The brachytherapy isotopes are sold under the brandname Blu. The company went public in 2005. Isoray’s corporate headquarters is located at 350 Hills Street, Suite 106, Richland WA 99354.

2BB score and signals

Perspective Therapeutics’s current 2BB score is 40 out of 100, built from the signal categories below.

SignalScoreReading
Activity53Moderate
Momentum42Stable
Financial strength5Very Weak
Quality95Very Strong
Risk57Moderate

Company facts

HeadquartersSeattle, Washington, United States
Founded2004
Employees163
52-week range$1.96 – $6.16